Back in August, it was reported that a simple pill taken at the onset of symptoms for COVID-19 reduced the risk of hospitalization and death by 50%. Now 1.7 million doses of that drug, an antiviral agent called Molnupiravir produced by Merck, have been secured for use in the U.S. and represents the first orally-ingested […]
The post Promising Results From Antiviral Pill May Change the Game for COVID-19 Effects, Finds Clinical Trial appeared first on Good News Network.
from Good News Network https://ift.tt/3BfJAdd
via IFTTT
No comments:
Post a Comment